Gainers
- Singular Genomics Sys OMIC shares moved upwards by 17.9% to $0.66 during Friday's after-market session. The market value of their outstanding shares is at $48.4 million.
- Vaccinex VCNX stock increased by 11.61% to $0.77. The company's market cap stands at $9.6 million.
- Celularity CELU shares moved upwards by 7.52% to $0.46. The market value of their outstanding shares is at $99.5 million.
- ZyVersa Therapeutics ZVSA stock rose 6.87% to $0.62. The company's market cap stands at $1.0 million.
- BioXcel Therapeutics BTAI stock moved upwards by 5.21% to $2.22. The company's market cap stands at $66.4 million.
- Turnstone Biologics TSBX shares rose 4.62% to $2.26. The market value of their outstanding shares is at $52.1 million.
Losers
- Intelligent Bio Solutions INBS stock declined by 15.8% to $5.7 during Friday's after-market session. The market value of their outstanding shares is at $4.1 million.
- Perspective Therapeutics CATX stock fell 8.9% to $0.82. The company's market cap stands at $405.5 million.
- NanoString Technologies NSTG stock decreased by 7.83% to $0.21. The market value of their outstanding shares is at $10.2 million.
- Bone Biologics BBLG shares declined by 6.36% to $3.83. The company's market cap stands at $2.0 million.
- Actinium Pharma ATNM stock decreased by 4.95% to $5.19. The market value of their outstanding shares is at $144.0 million.
- Biolase BIOL stock declined by 4.94% to $0.48. The company's market cap stands at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BBLGBone Biologics Corp
$0.9500-3.87%
BIOLBiolase Inc COM PAR $.001 NEW
$0.0680291.9%
BTAIBioXcel Therapeutics Inc
$0.35111.36%
CATXPerspective Therapeutics Inc
$3.284.41%
CELUCelularity Inc
$2.26-0.88%
INBSIntelligent Bio Solutions Inc
$1.393.73%
OMICSingular Genomics Systems Inc
$19.400.72%
TSBXTurnstone Biologics Corp
$0.46583.03%
VCNXVaccinex Inc
$1.01-28.4%
ZVSAZyVersa Therapeutics Inc
$1.15-1.71%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in